<?xml version="1.0" ?>
<proxyVoteTable xmlns="http://www.sec.gov/edgar/document/npxproxy/informationtable">
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Appointment of Mr. Srinivas Akkaraju, as Director of the Company.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Approval of the compensation policy for the Chief Executive Officer (application from the date of separation of functions).</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Approval of the compensation policy of the Chairperson of the Board of Directors (application from the date of separation of functions).</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Capital increase in cash for a nominal amount of EUR 78,720.64 by issuance of ordinary shares, without shareholders' preemptive subscription rights to the benefit of named persons and delegation of authority to the Board of Directors.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for New Enterprise Associates 17, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Growth Equity Opportunities 18 VGE, LLC.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Sofinnova Crossover I SLP.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Yiheng Capital Management, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>Abstain</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>AGAINST</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for BioDiscovery 6 FPCI.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Invus Public Equities, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Samsara BioCapital, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Perceptive Life Sciences Master Fund, Ltd.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for CVI Investments Inc.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Biomedical Value Fund, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Biomedical Offshore Value Fund, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Schonfeld Global Master Fund, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Eventide Healthcare Innovation Fund I, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Adage Capital Partners, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Altamont Pharmaceutical Holdings, LLC, sub-fund of Avondale ICAV.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Albemarle Life Sciences Fund, sub-fund of Avondale ICAV.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for KVP Capital, LP.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Decision to issue 8,053,847 pre-funded warrants of the Company without shareholders' preemptive subscription rights to the benefit of named persons and delegation of authority to the Board of Directors.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Biotechnology Value Fund, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Biotechnology Value Fund II, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Biotechnology Value Trading Fund OS, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for MSI BVF SPV, LLC.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for New Enterprise Associates 17, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Growth Equity Opportunities 18 VGE, LLC.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Samsara BioCapital, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Perceptive Life Sciences Master Fund, Ltd.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Deep Track Biotechnology Master Fund, Ltd.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Capital increase by issuance of shares with warrants attached, without shareholders' preemptive subscription rights to the benefit of named persons and delegation of authority to the Board of Directors.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Sofinnova Crossover I SLP.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Yiheng Capital Management, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>Abstain</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>AGAINST</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for BioDiscovery 6 FPCI.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Invus Public Equities, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Samsara BioCapital, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Perceptive Life Sciences Master Fund, Ltd.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for CVI Investments Inc.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Biomedical Value Fund, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Biomedical Offshore Value Fund, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Schonfeld Global Master Fund, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Eventide Healthcare Innovation Fund I, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Adage Capital Partners, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Altamont Pharmaceutical Holdings, LLC.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Albemarle Life Sciences Fund, sub-fund of Avondale ICAV.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for KVP Capital, LP.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Decision to issue pre-funded warrants with share subscription warrants attached, without shareholders' preemptive subscription rights to the benefit of named persons and delegation of authority to the Board of Directors.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Biotechnology Value Fund, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Biotechnology Value Fund II, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Biotechnology Value Trading Fund OS, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for MSI BVF SPV, LLC.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for New Enterprise Associates 17, L.P.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Growth Equity Opportunities 18 VGE, LLC.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Perceptive Life Sciences Master Fund, Ltd.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Cancellation of the preemptive subscription rights for Deep Track Biotechnology Master Fund, Ltd.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Delegation of authority to the Board of Directors to increase the share capital of the Company by issuance of ordinary shares or securities giving access to the share capital of the Company, immediately or in the future, reserved for certain specific categories of beneficiaries, without shareholders' preemptive subscription rights.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Delegation of authority to the Board of Directors to increase the share capital of the Company by issuance of ordinary shares or securities giving access to the share capital of the Company immediately or in the future by the Company reserved for members of a company savings plan to be set up by the Company under the conditions provided for in Article L.3332-18 et seq. of the French Code du travail, without shareholders' preferential subscription rights.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>Against</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Authorization to the Board of Directors to grant free shares to employees and/or certain corporate officers.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>Against</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>AGAINST</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Authorization to the Board of Directors to grant share subscription and/or share purchase options to corporate officers and employees of the Company or companies of the group, entailing the waiver by shareholders of their preferential rights to subscribe for shares issued following the exercise of stock options.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Delegation of authority to the Board of Directors to decide on the issuance of share subscription warrants, without shareholders' preemptive subscription rights, to the benefit of categories of persons.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Modification of the overall limit on the maximum authorized amounts set under the resolutions twenty-first to twenty-third, twenty-sixth, twenty-eighth and twenty-ninth resolutions of the General Meeting dated June 20, 2024.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Amendment of the Company's policy for the Company's directors.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Amendment of the Deputy Chief Executive Officer's compensation policy.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>12/11/2024</meetingDate>
		<voteDescription>Powers to carry out formalities.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>2202293</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>2202293</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>SILVACO GROUP, INC.</issuerName>
		<cusip>82728C102</cusip>
		<isin>US82728C1027</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Election of Director: Anita Ganti</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>835385</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>835385</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>SILVACO GROUP, INC.</issuerName>
		<cusip>82728C102</cusip>
		<isin>US82728C1027</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Election of Director: Hau Lee</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>835385</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>835385</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>SILVACO GROUP, INC.</issuerName>
		<cusip>82728C102</cusip>
		<isin>US82728C1027</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Election of Director: William H. Molloie, Jr.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>835385</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>835385</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>SILVACO GROUP, INC.</issuerName>
		<cusip>82728C102</cusip>
		<isin>US82728C1027</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Election of Director: Anthony Ngai</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>835385</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>835385</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>SILVACO GROUP, INC.</issuerName>
		<cusip>82728C102</cusip>
		<isin>US82728C1027</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Election of Director: Katherine Ngai-Pesic</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>835385</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>835385</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>SILVACO GROUP, INC.</issuerName>
		<cusip>82728C102</cusip>
		<isin>US82728C1027</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Election of Director: Iliya Pesic</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>835385</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>835385</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>SILVACO GROUP, INC.</issuerName>
		<cusip>82728C102</cusip>
		<isin>US82728C1027</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Election of Director: Walden Rhines</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>835385</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>835385</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>SILVACO GROUP, INC.</issuerName>
		<cusip>82728C102</cusip>
		<isin>US82728C1027</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Election of Director: Jodi Shelton</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>835385</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>835385</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>SILVACO GROUP, INC.</issuerName>
		<cusip>82728C102</cusip>
		<isin>US82728C1027</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Election of Director: Babak A. Taheri</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>835385</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>835385</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>SILVACO GROUP, INC.</issuerName>
		<cusip>82728C102</cusip>
		<isin>US82728C1027</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Proposal to approve an amendment and restatement of the Company's amended and restated certificate of incorporation to allow for the removal of directors by the stockholders without cause</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>835385</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>835385</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Approval of the statutory financial statements for the financial year ended December 31, 2024.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Approval of the consolidated financial statements for the financial year ended December 31, 2024.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Appropriation of profit/loss for the financial year ended December 31, 2024.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Approval of the expenses and charges referred to in Article 39(4) of the French General Tax Code.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Approval of the subscription agreement for royalty certificates issued by the Company signed on July 17, 2024 between the Company and Biotechnology Value Fund Partners L.P., in accordance with Articles L.225-38 et seq. of the French Commercial Code.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Approval of the subscription agreement for new shares and pre- funded warrants issued by the Company signed on October 17, 2024 between the Company and Biotechnology Value Fund Partners L.P., in accordance with Articles L.225-38 et seq. of the French Commercial Code.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Approval of the transfer of know-how and communication agreement signed on December 11, 2024 between the Company and its Deputy Chief Executive Officer, in accordance with Articles L.225-38 et seq. of the French Commercial Code.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Approval of the subscription agreement for new shares issued by the Company signed on December 13, 2024 between the Company and Samsara BioCapital L.P., in accordance with Articles L.225-38 et seq. of the French Commercial Code.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Approval of the subscription agreement for pre-funded warrants issued by the Company signed on December 13, 2024 between the Company and Samsara BioCapital L.P., in accordance with Articles L.225-38 et seq. of the French Commercial Code.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Final approval of the fixed and variable compensation paid or awarded to Mr. Mark Pruzanski in his capacity as Chairman of the Board of Directors for the financial year ended December 31, 2024 (from December 13, 2024).</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Final approval of the fixed and variable compensation paid or awarded to Mr. Fr&#233;d&#233;ric Cren in his capacity as Chairman of the Board of Directors and Chief Executive Officer until December 13, 2024 and as Chief Executive Officer from December 13, 2024 for the financial year ended December 31, 2024.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Final approval of the fixed and variable compensation paid or awarded to Mr. Pierre Broqua in his capacity as Deputy Chief Executive Officer for the financial year ended December 31, 2024.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Approval of the information on corporate officers' compensation included in the corporate governance report and referred to in Article L.22-10-9 I. of the French Commercial Code.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Approval of the compensation policy for Mr. Mark Pruzanski in his capacity as Chairman of the Board of Directors.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Approval of the compensation policy for Mr. Fr&#233;d&#233;ric Cren in his capacity as Chief Executive Officer.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Approval of the compensation policy for Mr. Pierre Broqua in his capacity as Deputy Chief Executive Officer.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Total compensation paid to members of the Board of Directors.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Approval of the compensation policy of the Company's directors.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Appointment of Ms. Ren&#233;e Aguiar- Lucander, as Director of the Company.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Renewal of the Director's mandate of Mr. Fr&#233;d&#233;ric Cren.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Renewal of the Director's mandate of Cell+.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>Abstain</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>AGAINST</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Authorization granted to the Board of Directors to buyback the Company's shares.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Authorization to the Board of Directors to reduce the share capital by cancellation of shares.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Delegation of authority to the Board of Directors to increase the share capital of the Company by issuance of ordinary shares or securities giving access to the share capital of the Company, immediately or in the future, with shareholders' preemptive subscription rights maintained.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Delegation of authority to the Board of Directors to increase the share capital of the Company by issuance of ordinary shares or securities giving access to the share capital of the Company, immediately or in the future, without shareholders' preemptive subscription rights, by way of public offerings, excluding offers referred to in Article L.411-2- 1&#176; of the French Code mon&#233;taire et financier.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Delegation of authority to the Board of Directors to increase the share capital of the Company by issuance of ordinary shares or securities giving access to the share capital of the Company, immediately or in the future, without shareholders' preemptive subscription rights, by way of public offerings referred to in Article L.411-2 1&#176; of the French Code mon&#233;taire et financier.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Delegation of authority to the Board of Directors to increase the share capital of the company by issuance of ordinary shares or securities giving access to the share capital of the Company, immediately or in the future, reserved for certain specific categories of beneficiaries, without shareholders' preemptive subscription rights.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Delegation of authority to the Board of Directors to increase the share capital of the company by issuance of ordinary shares or securities giving access to the share capital of the Company, immediately or in the future, in favor of one or more persons specifically designated by the Board of Directors, without shareholders' preemptive subscription rights.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Delegation of authority to the Board of Directors to increase the share capital of the company by issuance of ordinary shares, immediately or in the future, reserved for certain specific categories of beneficiaries meeting specific characteristics within the framework of an equity financing agreement on the U.S. market called "At-the-market" or "ATM", without shareholders' preemptive subscription rights.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Authorization to the Board of Directors to increase the number of securities to be issued as part of share capital increases with or without shareholders' preemptive subscription rights.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Delegation of authority to the Board of Directors to increase the share capital of the Company by issuance of ordinary shares and securities giving access to the share capital of the Company, immediately or in the future, as part of a public exchange offer initiated by the Company.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Delegation of authority to the Board of Directors to increase the share capital of the Company by issuance of ordinary shares or securities giving access to the share capital of the Company, immediately or in the future, in consideration for contributions in kind within the limits set by legal and regulatory provisions, excluding the case of a public exchange offer initiated by the Company.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Delegation of authority to the Board of Directors to increase the share capital of the Company by issuance of ordinary shares or securities giving access to the share capital of the Company immediately or in the future by the company reserved for members of a company savings plan to be set up by the Company under the conditions provided for in Article L.3332-18 et seq. of the French Code du travail, without shareholders' preferential subscription rights.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>AGAINST</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Delegation of authority to the Board of Directors to increase the share capital of the Company by incorporating reserves, profits or premiums.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Decision to be taken in application of article L. 225-248 of the French Commercial Code (shareholders' equity less than half the share capital).</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Harmonization of the articles of association of the Company with applicable laws and regulations, including some provisions of the French Law no. 2024-537 of June 13, 2024 aimed at increasing business financing and France's attractiveness.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>INVENTIVA S.A.</issuerName>
		<cusip>46124U107</cusip>
		<isin>US46124U1079</isin>
		<meetingDate>05/22/2025</meetingDate>
		<voteDescription>Power for formalities.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>836646</sharesVoted>
		<sharesOnLoan>423189</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>836646</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>ROBLOX CORPORATION</issuerName>
		<cusip>771049103</cusip>
		<isin>US7710491033</isin>
		<meetingDate>05/29/2025</meetingDate>
		<voteDescription>Christopher Carvalho</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>196392</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>Withheld</howVoted>
			<sharesVoted>196392</sharesVoted>
			<managementRecommendation>AGAINST</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>ROBLOX CORPORATION</issuerName>
		<cusip>771049103</cusip>
		<isin>US7710491033</isin>
		<meetingDate>05/29/2025</meetingDate>
		<voteDescription>Gina Mastantuono</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>196392</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>Withheld</howVoted>
			<sharesVoted>196392</sharesVoted>
			<managementRecommendation>AGAINST</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>ROBLOX CORPORATION</issuerName>
		<cusip>771049103</cusip>
		<isin>US7710491033</isin>
		<meetingDate>05/29/2025</meetingDate>
		<voteDescription>Jason Kilar</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>196392</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>Withheld</howVoted>
			<sharesVoted>196392</sharesVoted>
			<managementRecommendation>AGAINST</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>ROBLOX CORPORATION</issuerName>
		<cusip>771049103</cusip>
		<isin>US7710491033</isin>
		<meetingDate>05/29/2025</meetingDate>
		<voteDescription>Advisory Vote on the Compensation of our Named Executive Officers.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>196392</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>Against</howVoted>
			<sharesVoted>196392</sharesVoted>
			<managementRecommendation>AGAINST</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>ROBLOX CORPORATION</issuerName>
		<cusip>771049103</cusip>
		<isin>US7710491033</isin>
		<meetingDate>05/29/2025</meetingDate>
		<voteDescription>Ratification of Independent Registered Public Accounting Firm.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>196392</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>Against</howVoted>
			<sharesVoted>196392</sharesVoted>
			<managementRecommendation>AGAINST</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>ROBLOX CORPORATION</issuerName>
		<cusip>771049103</cusip>
		<isin>US7710491033</isin>
		<meetingDate>05/29/2025</meetingDate>
		<voteDescription>Approval of the Reincorporation in Nevada by Conversion.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>196392</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>Against</howVoted>
			<sharesVoted>196392</sharesVoted>
			<managementRecommendation>AGAINST</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DENALI THERAPEUTICS INC.</issuerName>
		<cusip>24823R105</cusip>
		<isin>US24823R1059</isin>
		<meetingDate>06/03/2025</meetingDate>
		<voteDescription>Julian Baker</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>318239</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>318239</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DENALI THERAPEUTICS INC.</issuerName>
		<cusip>24823R105</cusip>
		<isin>US24823R1059</isin>
		<meetingDate>06/03/2025</meetingDate>
		<voteDescription>Peter Klein</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>318239</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>318239</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DENALI THERAPEUTICS INC.</issuerName>
		<cusip>24823R105</cusip>
		<isin>US24823R1059</isin>
		<meetingDate>06/03/2025</meetingDate>
		<voteDescription>Steve Krognes</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>318239</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>318239</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DENALI THERAPEUTICS INC.</issuerName>
		<cusip>24823R105</cusip>
		<isin>US24823R1059</isin>
		<meetingDate>06/03/2025</meetingDate>
		<voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>318239</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>318239</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DENALI THERAPEUTICS INC.</issuerName>
		<cusip>24823R105</cusip>
		<isin>US24823R1059</isin>
		<meetingDate>06/03/2025</meetingDate>
		<voteDescription>Advisory vote on executive compensation</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>318239</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>318239</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>AKERO THERAPEUTICS, INC</issuerName>
		<cusip>00973Y108</cusip>
		<isin>US00973Y1082</isin>
		<meetingDate>06/03/2025</meetingDate>
		<voteDescription>Judy Chou, Ph.D.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>176260</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>176260</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>AKERO THERAPEUTICS, INC</issuerName>
		<cusip>00973Y108</cusip>
		<isin>US00973Y1082</isin>
		<meetingDate>06/03/2025</meetingDate>
		<voteDescription>Tomas Heyman</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>176260</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>176260</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>AKERO THERAPEUTICS, INC</issuerName>
		<cusip>00973Y108</cusip>
		<isin>US00973Y1082</isin>
		<meetingDate>06/03/2025</meetingDate>
		<voteDescription>To ratify the appointment of Deloitte &amp; Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>176260</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>176260</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>AKERO THERAPEUTICS, INC</issuerName>
		<cusip>00973Y108</cusip>
		<isin>US00973Y1082</isin>
		<meetingDate>06/03/2025</meetingDate>
		<voteDescription>To consider and act upon a non-binding, advisory vote to approve the compensation of our named executive officers.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>176260</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>176260</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>BEAM THERAPEUTICS INC.</issuerName>
		<cusip>07373V105</cusip>
		<isin>US07373V1052</isin>
		<meetingDate>06/04/2025</meetingDate>
		<voteDescription>Election of Class II Director for three-year terms ending at our Annual Meeting of Stockholders to be held in 2028: Mark Fishman, M.D.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>69058</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>69058</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>BEAM THERAPEUTICS INC.</issuerName>
		<cusip>07373V105</cusip>
		<isin>US07373V1052</isin>
		<meetingDate>06/04/2025</meetingDate>
		<voteDescription>Election of Class II Director for three-year terms ending at our Annual Meeting of Stockholders to be held in 2028: Carole Ho, M.D.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>69058</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>69058</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>BEAM THERAPEUTICS INC.</issuerName>
		<cusip>07373V105</cusip>
		<isin>US07373V1052</isin>
		<meetingDate>06/04/2025</meetingDate>
		<voteDescription>Election of Class II Director for three-year terms ending at our Annual Meeting of Stockholders to be held in 2028: Kathleen Walsh</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>69058</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>69058</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>BEAM THERAPEUTICS INC.</issuerName>
		<cusip>07373V105</cusip>
		<isin>US07373V1052</isin>
		<meetingDate>06/04/2025</meetingDate>
		<voteDescription>Ratify the appointment of Deloitte &amp; Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>69058</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>69058</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>BEAM THERAPEUTICS INC.</issuerName>
		<cusip>07373V105</cusip>
		<isin>US07373V1052</isin>
		<meetingDate>06/04/2025</meetingDate>
		<voteDescription>Approve, on an advisory basis, the compensation of our named executive officers.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>69058</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>69058</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>GENERATION BIO CO.</issuerName>
		<cusip>37148K100</cusip>
		<isin>US37148K1007</isin>
		<meetingDate>06/04/2025</meetingDate>
		<voteDescription>Ron Cooper</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>341725</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>341725</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>GENERATION BIO CO.</issuerName>
		<cusip>37148K100</cusip>
		<isin>US37148K1007</isin>
		<meetingDate>06/04/2025</meetingDate>
		<voteDescription>Anthony Q. MB Ch.B. PhD</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>341725</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>341725</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>GENERATION BIO CO.</issuerName>
		<cusip>37148K100</cusip>
		<isin>US37148K1007</isin>
		<meetingDate>06/04/2025</meetingDate>
		<voteDescription>Jason Rhodes</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>341725</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>341725</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>GENERATION BIO CO.</issuerName>
		<cusip>37148K100</cusip>
		<isin>US37148K1007</isin>
		<meetingDate>06/04/2025</meetingDate>
		<voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>341725</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>341725</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>GENERATION BIO CO.</issuerName>
		<cusip>37148K100</cusip>
		<isin>US37148K1007</isin>
		<meetingDate>06/04/2025</meetingDate>
		<voteDescription>Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>341725</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>341725</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>GENERATION BIO CO.</issuerName>
		<cusip>37148K100</cusip>
		<isin>US37148K1007</isin>
		<meetingDate>06/04/2025</meetingDate>
		<voteDescription>Adoption and approval of an amendment to our restated certificate of incorporation to effect a reverse stock split of our issued shares of common stock at a ratio within the range of not less than 1-for-10 and not greater than 1-for-30, without reducing the authorized number of shares of our common stock, with the exact ratio within such range and the implementation and timing of such reverse stock split to be determined at the sole discretion of our board of directors, without further approval or authorization of our stockholders.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>341725</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>Against</howVoted>
			<sharesVoted>341725</sharesVoted>
			<managementRecommendation>AGAINST</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>DBV TECHNOLOGIES S.A.</issuerName>
		<cusip>23306J309</cusip>
		<isin>US23306J3095</isin>
		<meetingDate>06/11/2025</meetingDate>
		<voteDescription>Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>476373</sharesVoted>
		<sharesOnLoan>173500</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>476373</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>ACM RESEARCH, INC.</issuerName>
		<cusip>00108J109</cusip>
		<isin>US00108J1097</isin>
		<meetingDate>06/12/2025</meetingDate>
		<voteDescription>Election of Director: Haiping Dun</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>153231</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>153231</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>ACM RESEARCH, INC.</issuerName>
		<cusip>00108J109</cusip>
		<isin>US00108J1097</isin>
		<meetingDate>06/12/2025</meetingDate>
		<voteDescription>Election of Director: Tracy Liu</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>153231</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>153231</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>ACM RESEARCH, INC.</issuerName>
		<cusip>00108J109</cusip>
		<isin>US00108J1097</isin>
		<meetingDate>06/12/2025</meetingDate>
		<voteDescription>Election of Director: David H. Wang</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>153231</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>153231</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>ACM RESEARCH, INC.</issuerName>
		<cusip>00108J109</cusip>
		<isin>US00108J1097</isin>
		<meetingDate>06/12/2025</meetingDate>
		<voteDescription>Election of Director: Charlie Pappis</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>153231</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>153231</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>ACM RESEARCH, INC.</issuerName>
		<cusip>00108J109</cusip>
		<isin>US00108J1097</isin>
		<meetingDate>06/12/2025</meetingDate>
		<voteDescription>Ratification of appointment of Ernst &amp; Young Hua Ming LLP as independent auditor for year 2025.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>153231</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>153231</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>NOAH HOLDINGS LIMITED</issuerName>
		<cusip>65487X102</cusip>
		<isin>US65487X1028</isin>
		<meetingDate>06/12/2025</meetingDate>
		<voteDescription>To receive and consider the audited consolidated financial statements of the Company and the reports of the directors and auditor of the Company for the year ended December 31, 2024.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>6719722</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>6719722</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>NOAH HOLDINGS LIMITED</issuerName>
		<cusip>65487X102</cusip>
		<isin>US65487X1028</isin>
		<meetingDate>06/12/2025</meetingDate>
		<voteDescription>Re-election of Director: Ms. Jingbo Wang to serve as a Director, subject to her earlier resignation or removal</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>6719722</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>6719722</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>NOAH HOLDINGS LIMITED</issuerName>
		<cusip>65487X102</cusip>
		<isin>US65487X1028</isin>
		<meetingDate>06/12/2025</meetingDate>
		<voteDescription>Re-election of Director: Mr. Zhe Yin to serve as a Director, subject to his earlier resignation or removal</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>6719722</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>6719722</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>NOAH HOLDINGS LIMITED</issuerName>
		<cusip>65487X102</cusip>
		<isin>US65487X1028</isin>
		<meetingDate>06/12/2025</meetingDate>
		<voteDescription>Re-election of Director: Mr. David Zhang to serve as a non- executive Director under the Hong Kong Listing Rules and an independent Director under the rules and regulations of the NYSE, subject to his earlier resignation or removal</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>6719722</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>6719722</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>NOAH HOLDINGS LIMITED</issuerName>
		<cusip>65487X102</cusip>
		<isin>US65487X1028</isin>
		<meetingDate>06/12/2025</meetingDate>
		<voteDescription>Re-election of Director: Ms. Xiangrong Li to serve as an independent Director, subject to her earlier resignation or removal</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>6719722</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>6719722</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>NOAH HOLDINGS LIMITED</issuerName>
		<cusip>65487X102</cusip>
		<isin>US65487X1028</isin>
		<meetingDate>06/12/2025</meetingDate>
		<voteDescription>To authorize the Board to fix the remuneration of the Directors.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>6719722</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>6719722</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>NOAH HOLDINGS LIMITED</issuerName>
		<cusip>65487X102</cusip>
		<isin>US65487X1028</isin>
		<meetingDate>06/12/2025</meetingDate>
		<voteDescription>To consider, approve and declare Final Dividend of RMB275.0 million (approximately US$37.7 million) in aggregate in respect of the year ended December 31, 2024, which will be paid out of the corporate actions budget equivalent to 50% of the non-GAAP net income attributable to Shareholders during the year ended December 31, 2024 to Shareholders whose names appear on the register of members of the Company as of the Dividend Record Date; if declared and paid, a Final Dividend of RMB0.826 ...(due to space limits, see proxy material for full proposal).</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>6719722</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>6719722</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>NOAH HOLDINGS LIMITED</issuerName>
		<cusip>65487X102</cusip>
		<isin>US65487X1028</isin>
		<meetingDate>06/12/2025</meetingDate>
		<voteDescription>To consider, approve and declare Special Dividend of RMB275.0 million (approximately US$37.7 million) in aggregate, which will be paid out of the accumulated return surplus cash from the years prior to 2024, to Shareholders whose names appear on the register of members of the Company as of the Dividend Record Date; if declared and paid, a non-recurring Special Dividend of RMB0.826 (equivalent to approximately US$0.113, or approximately HK$0.879) per share (tax inclusive) will be paid out to ...(due to space limits, see proxy material for full proposal).</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>6719722</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>6719722</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>NOAH HOLDINGS LIMITED</issuerName>
		<cusip>65487X102</cusip>
		<isin>US65487X1028</isin>
		<meetingDate>06/12/2025</meetingDate>
		<voteDescription>To re-appoint Deloitte Touche Tohmatsu as the auditors of the Company to hold office until the conclusion of the next annual general meeting of the Company and to authorize the Board to fix its remuneration for the year ending December 31, 2025.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>6719722</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>6719722</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>NOAH HOLDINGS LIMITED</issuerName>
		<cusip>65487X102</cusip>
		<isin>US65487X1028</isin>
		<meetingDate>06/12/2025</meetingDate>
		<voteDescription>To grant of an issuance mandate (the "Issuance Mandate") to the Board to issue, allot or deal with additional Shares and/or ADSs (including any sale or transfer of treasury Shares) not exceeding 20% of the total number of issued Shares of the Company (excluding treasury Shares) as of the date of passing of this ordinary resolution.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>6719722</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>6719722</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>NOAH HOLDINGS LIMITED</issuerName>
		<cusip>65487X102</cusip>
		<isin>US65487X1028</isin>
		<meetingDate>06/12/2025</meetingDate>
		<voteDescription>To grant a repurchase mandate (the "Repurchase Mandate") to the Board to repurchase Shares and/or ADSs not exceeding 10% of the total number of issued Shares of the Company (excluding treasury Shares) as of the date of passing of this ordinary resolution.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>6719722</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>6719722</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>NOAH HOLDINGS LIMITED</issuerName>
		<cusip>65487X102</cusip>
		<isin>US65487X1028</isin>
		<meetingDate>06/12/2025</meetingDate>
		<voteDescription>Conditional upon passing of resolutions numbered 5(A) and 5(B) above, to extend the Issuance Mandate by adding the number of repurchased Shares and/or Shares underlying the ADSs under the Repurchase Mandate to the total number of Shares and/or Shares underlying the ADSs which may be allotted and issued by the Directors pursuant to the Issuance Mandate, provided that such amount shall not exceed 10% of the number of the issued Shares (excluding treasury Shares) as of the date of passing of this resolution.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>6719722</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>6719722</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>VIRIDIAN THERAPEUTICS, INC.</issuerName>
		<cusip>92790C104</cusip>
		<isin>US92790C1045</isin>
		<meetingDate>06/20/2025</meetingDate>
		<voteDescription>Election of Class I Director to serve until the 2028 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Jeff Ajer</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>278786</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>278786</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>VIRIDIAN THERAPEUTICS, INC.</issuerName>
		<cusip>92790C104</cusip>
		<isin>US92790C1045</isin>
		<meetingDate>06/20/2025</meetingDate>
		<voteDescription>Election of Class I Director to serve until the 2028 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Chris Cain, Ph.D.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>278786</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>278786</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>VIRIDIAN THERAPEUTICS, INC.</issuerName>
		<cusip>92790C104</cusip>
		<isin>US92790C1045</isin>
		<meetingDate>06/20/2025</meetingDate>
		<voteDescription>Election of Class I Director to serve until the 2028 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Sarah Gheuens, M.D., Ph.D.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>278786</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>278786</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>VIRIDIAN THERAPEUTICS, INC.</issuerName>
		<cusip>92790C104</cusip>
		<isin>US92790C1045</isin>
		<meetingDate>06/20/2025</meetingDate>
		<voteDescription>To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>278786</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>278786</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>VIRIDIAN THERAPEUTICS, INC.</issuerName>
		<cusip>92790C104</cusip>
		<isin>US92790C1045</isin>
		<meetingDate>06/20/2025</meetingDate>
		<voteDescription>To approve, on an advisory basis, the compensation of the Company's named executive officers.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>278786</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>278786</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>VIRIDIAN THERAPEUTICS, INC.</issuerName>
		<cusip>92790C104</cusip>
		<isin>US92790C1045</isin>
		<meetingDate>06/20/2025</meetingDate>
		<voteDescription>To approve a further amendment and restatement of the Company's Amended and Restated 2016 Equity Incentive Plan, including increasing the number of shares available for issuance thereunder by 8,000,000 shares.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>278786</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>278786</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>VIRIDIAN THERAPEUTICS, INC.</issuerName>
		<cusip>92790C104</cusip>
		<isin>US92790C1045</isin>
		<meetingDate>06/20/2025</meetingDate>
		<voteDescription>To approve the Viridian Therapeutics, Inc. 2025 Employee Stock Purchase Plan.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>278786</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>278786</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>BILIBILI INC</issuerName>
		<cusip>90040106</cusip>
		<isin>US0900401060</isin>
		<meetingDate>06/20/2025</meetingDate>
		<voteDescription>As an ordinary resolution: THAT the audited consolidated financial statements of the Company and the reports of the directors and auditors of the Company for the year ended December 31, 2024 be received</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>1019855</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>Abstain</howVoted>
			<sharesVoted>1019855</sharesVoted>
			<managementRecommendation>NONE</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>BILIBILI INC</issuerName>
		<cusip>90040106</cusip>
		<isin>US0900401060</isin>
		<meetingDate>06/20/2025</meetingDate>
		<voteDescription>As an ordinary resolution: THAT Ni Li be re- elected to serve as a director until the 2028 annual general meeting of shareholders and until her successor is duly elected and qualified, subject to her earlier resignation or removal</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>1019855</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>Abstain</howVoted>
			<sharesVoted>1019855</sharesVoted>
			<managementRecommendation>AGAINST</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>BILIBILI INC</issuerName>
		<cusip>90040106</cusip>
		<isin>US0900401060</isin>
		<meetingDate>06/20/2025</meetingDate>
		<voteDescription>As an ordinary resolution: THAT Yi Xu be re-elected to serve as a director until the 2028 annual general meeting of shareholders and until his successor is duly elected and qualified, subject to his earlier resignation or removal</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>1019855</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>Abstain</howVoted>
			<sharesVoted>1019855</sharesVoted>
			<managementRecommendation>AGAINST</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>BILIBILI INC</issuerName>
		<cusip>90040106</cusip>
		<isin>US0900401060</isin>
		<meetingDate>06/20/2025</meetingDate>
		<voteDescription>As an ordinary resolution: THAT Feng Li be re-elected to serve as an independent director until the 2028 annual general meeting of shareholders and until his successor is duly elected and qualified, subject to his earlier resignation or removal</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>1019855</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>Abstain</howVoted>
			<sharesVoted>1019855</sharesVoted>
			<managementRecommendation>AGAINST</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>BILIBILI INC</issuerName>
		<cusip>90040106</cusip>
		<isin>US0900401060</isin>
		<meetingDate>06/20/2025</meetingDate>
		<voteDescription>As an ordinary resolution: THAT authorize the Board to fix the remuneration of the directors</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>1019855</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>Abstain</howVoted>
			<sharesVoted>1019855</sharesVoted>
			<managementRecommendation>AGAINST</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>BILIBILI INC</issuerName>
		<cusip>90040106</cusip>
		<isin>US0900401060</isin>
		<meetingDate>06/20/2025</meetingDate>
		<voteDescription>As an ordinary resolution: THAT PricewaterhouseCoopers and PricewaterhouseCoopers Zhong Tian LLP be re-appointed as auditors of the Company to hold office until the conclusion of the next annual general meeting of the Company and to authorize the Board to fix their remuneration for the year ending December 31, 2025</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>1019855</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>Abstain</howVoted>
			<sharesVoted>1019855</sharesVoted>
			<managementRecommendation>AGAINST</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>BILIBILI INC</issuerName>
		<cusip>90040106</cusip>
		<isin>US0900401060</isin>
		<meetingDate>06/20/2025</meetingDate>
		<voteDescription>As an ordinary resolution: THAT a general mandate be granted to the directors to issue, allot, and deal with additional Class Z ordinary shares of the Company (including any sale or transfer of treasury shares out of treasury) not exceeding 20% of the total number of issued Shares of the Company (excluding treasury shares) as of the date of passing of this resolution</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>1019855</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>Abstain</howVoted>
			<sharesVoted>1019855</sharesVoted>
			<managementRecommendation>AGAINST</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>BILIBILI INC</issuerName>
		<cusip>90040106</cusip>
		<isin>US0900401060</isin>
		<meetingDate>06/20/2025</meetingDate>
		<voteDescription>As an ordinary resolution: THAT a general mandate be granted to the directors to repurchase Class Z ordinary shares and/or ADSs of the Company not exceeding 10% of the total number of issued Shares of the Company (excluding treasury shares) as of the date of passing of this resolution</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>1019855</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>Abstain</howVoted>
			<sharesVoted>1019855</sharesVoted>
			<managementRecommendation>AGAINST</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>BILIBILI INC</issuerName>
		<cusip>90040106</cusip>
		<isin>US0900401060</isin>
		<meetingDate>06/20/2025</meetingDate>
		<voteDescription>As an ordinary resolution: THAT the general mandate granted to the directors to issue, allot, and deal with additional Shares in the capital of the Company (including any sale or transfer of treasury shares out of treasury) be extended by the aggregate number of the Shares and/or Shares underlying the ADSs repurchased by the Company</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>1019855</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>Abstain</howVoted>
			<sharesVoted>1019855</sharesVoted>
			<managementRecommendation>AGAINST</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>KYMERA THERAPEUTICS, INC.</issuerName>
		<cusip>501575104</cusip>
		<isin>US5015751044</isin>
		<meetingDate>06/25/2025</meetingDate>
		<voteDescription>Jeffrey Albers,J.D.,MBA</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>63854</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>63854</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>KYMERA THERAPEUTICS, INC.</issuerName>
		<cusip>501575104</cusip>
		<isin>US5015751044</isin>
		<meetingDate>06/25/2025</meetingDate>
		<voteDescription>Felix J. Baker, Ph.D.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>63854</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>63854</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>KYMERA THERAPEUTICS, INC.</issuerName>
		<cusip>501575104</cusip>
		<isin>US5015751044</isin>
		<meetingDate>06/25/2025</meetingDate>
		<voteDescription>To approve, on a non-binding advisory basis, the compensation of our named executive officers.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>63854</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>63854</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>KYMERA THERAPEUTICS, INC.</issuerName>
		<cusip>501575104</cusip>
		<isin>US5015751044</isin>
		<meetingDate>06/25/2025</meetingDate>
		<voteDescription>To ratify the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>63854</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>63854</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>H WORLD GROUP LIMITED</issuerName>
		<cusip>44332N106</cusip>
		<isin>US44332N1063</isin>
		<meetingDate>06/27/2025</meetingDate>
		<voteDescription>The ordinary resolution as set out in the Notice of Annual General Meeting regarding the ratification of appointment of Deloitte Touche Tohmatsu Certified Public Accountants LLP as auditor of the Company for 2025 and the authorization for the directors of the Company to determine the remuneration of the auditor.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>381853</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>381853</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>H WORLD GROUP LIMITED</issuerName>
		<cusip>44332N106</cusip>
		<isin>US44332N1063</isin>
		<meetingDate>06/27/2025</meetingDate>
		<voteDescription>The ordinary resolution as set out in the Notice of Annual General Meeting regarding the authorization of the re-election of Ms. Jie Zheng (appointed by the board of directors of the Company on July 2, 2024) as an executive director of the Company.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>381853</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>381853</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
	<proxyTable>
		<issuerName>H WORLD GROUP LIMITED</issuerName>
		<cusip>44332N106</cusip>
		<isin>US44332N1063</isin>
		<meetingDate>06/27/2025</meetingDate>
		<voteDescription>The ordinary resolution as set out in the Notice of Annual General Meeting regarding the authorization of each director or officer of the Company or Conyers Trust Company (Cayman) Limited to take any and every action that might be necessary, appropriate or desirable to effect the foregoing resolutions as such director, officer or Conyers Trust Company (Cayman) Limited, in his, her or its absolute discretion, thinks fit and to attend to any necessary registration and/or filing for and on behalf of the Company.</voteDescription>
		<voteCategories>
			<voteCategory>
				<categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
			</voteCategory>
	 	</voteCategories>
		<voteSource>ISSUER</voteSource>
		<sharesVoted>381853</sharesVoted>
		<sharesOnLoan>0</sharesOnLoan>
		<vote>
			<voteRecord>
			<howVoted>FOR</howVoted>
			<sharesVoted>381853</sharesVoted>
			<managementRecommendation>FOR</managementRecommendation>
			</voteRecord>
		</vote>
	</proxyTable>
</proxyVoteTable>
